{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T13:47:25Z","timestamp":1780494445262,"version":"3.54.1"},"reference-count":17,"publisher":"Japanese Society for the Study of Xenobiotics","issue":"3","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2013]]},"DOI":"10.2133\/dmpk.dmpk-12-rg-082","type":"journal-article","created":{"date-parts":[[2012,11,13]],"date-time":"2012-11-13T03:38:54Z","timestamp":1352777934000},"page":"213-219","source":"Crossref","is-referenced-by-count":72,"title":["Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Empagliflozin, a Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor, in Healthy Japanese Subjects"],"prefix":"10.2133","volume":"28","author":[{"given":"Akiko","family":"Sarashina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Koiwai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo J.","family":"Seman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Yamamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Negishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Sesoko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans J.","family":"Woerle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus A.","family":"Dugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"900","reference":[{"key":"10.2133\/dmpk.DMPK-12-RG-082_bb0005","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.diabres.2011.10.029","article-title":"IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030","volume":"94","author":"Whiting","year":"2011","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.2133\/dmpk.DMPK-12-RG-082_bb0010","first-page":"49","article-title":"Diabetes prevalence and body mass index differ by ethnicity: the Multiethnic Cohort","volume":"19","author":"Maskarinec","year":"2009","journal-title":"Ethn. Dis."},{"key":"10.2133\/dmpk.DMPK-12-RG-082_bb0015","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.diabres.2009.10.007","article-title":"Global estimates of the prevalence of diabetes for 2010 and 2030","volume":"87","author":"Shaw","year":"2010","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.2133\/dmpk.DMPK-12-RG-082_bb0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.tips.2010.11.011","article-title":"Renal glucose reabsorption inhibitors to treat diabetes","volume":"32","author":"Bailey","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"10.2133\/dmpk.DMPK-12-RG-082_bb0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00125-008-1157-y","article-title":"Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes","volume":"52","author":"Nathan","year":"2009","journal-title":"Diabetologia"},{"key":"10.2133\/dmpk.DMPK-12-RG-082_bb0030","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.39022.462546.80","article-title":"Management of hyperglycaemia in type 2 diabetes: the end of recurrent failure?","volume":"333","author":"Heine","year":"2006","journal-title":"BMJ"},{"key":"10.2133\/dmpk.DMPK-12-RG-082_bb0035","first-page":"S7","article-title":"Clinical practice in type 2 diabetes: After metformin and lifestyle, then what?","volume":"58","author":"Cobble","year":"2009","journal-title":"J. Fam. Pract."},{"key":"10.2133\/dmpk.DMPK-12-RG-082_bb0040","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1463-1326.2011.01517.x","article-title":"Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors","volume":"14","author":"Grempler","year":"2012","journal-title":"Diabetes Obes. Metab."},{"key":"10.2133\/dmpk.DMPK-12-RG-082_bb0045","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1463-1326.2011.01518.x","article-title":"Long-term treatment with empagliflozin, a novel, potent and selective SGLT-2 inhibitor, improves glycaemic control and features of metabolic syndrome in diabetic rats","volume":"14","author":"Thomas","year":"2012","journal-title":"Diabetes Obes. Metab."},{"key":"10.2133\/dmpk.DMPK-12-RG-082_bb0050","series-title":"Diabetes Obes Metab","article-title":"Safety, tolerability, pharmacokinetics and pharmacodynamics following 4 weeks' treatment with empagliflozin once daily in patients with type 2 diabetes","author":"Heise","year":"2013"},{"key":"10.2133\/dmpk.DMPK-12-RG-082_bb0055","series-title":"Clin. Pharm. in Drug Dev","article-title":"Empagliflozin (BI 10773), a potent and selective SGLT2 inhibitor, induces dose-dependent glucosuria in healthy subjects","author":"Seman","year":"2013"},{"key":"10.2133\/dmpk.DMPK-12-RG-082_bb0060","series-title":"Diabetes Obes Metab","article-title":"A phase IIb, randomised, placebo-controlled study of the SGLT2 inhibitor empagliflozin in patients with type 2 diabetes","author":"Ferrannini","year":"2013"},{"key":"10.2133\/dmpk.DMPK-12-RG-082_bb0065","first-page":"A271","article-title":"Efficacy and safety of BI 10773, a new sodium glucose cotransporter (SGLT-2) inhibitor, in type 2 diabetes inadequately controlled on metformin","volume":"60","author":"Rosenstock","year":"2011","journal-title":"Diabetes"},{"key":"10.2133\/dmpk.DMPK-12-RG-082_bb0070","first-page":"A156","article-title":"Safety and tolerability of BI 10773, a sodium-glucose co-transporter (SGLT-2) inhibitor, following 8-days treatment in patients with Type 2 diabetes","volume":"59","author":"Seman","year":"2010","journal-title":"Diabetes"},{"key":"10.2133\/dmpk.DMPK-12-RG-082_bb0075","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1046\/j.1523-1755.2001.0590051873.x","article-title":"Circadian rhythms in systemic hemodynamics and renal function in healthy subjects and patients with nephrotic syndrome","volume":"59","author":"Voogel","year":"2001","journal-title":"Kidney Int."},{"key":"10.2133\/dmpk.DMPK-12-RG-082_bb0080","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1172\/JCI104422","article-title":"Diurnal cycle of glomerular filtration rate and sodium and chloride excretion during responses to altered salt and water balance in man","volume":"40","author":"Wesson","year":"1961","journal-title":"J. Clin. Invest."},{"key":"10.2133\/dmpk.DMPK-12-RG-082_bb0085","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1210\/er.2010-0029","article-title":"Role of sodium-glucose cotransporter 2 (SGLT 2) inhibitors in the treatment of type 2 diabetes","volume":"32","author":"Abdul-Ghani","year":"2011","journal-title":"Endocr. Rev"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1347436715304043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1347436715304043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T02:36:53Z","timestamp":1498012613000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436715304043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"alternative-id":["S1347436715304043"],"URL":"https:\/\/doi.org\/10.2133\/dmpk.dmpk-12-rg-082","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]}}}